4
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Histopathological Factors in Malignant Melanoma

, , , &
Pages 271-274 | Accepted 30 Nov 1984, Published online: 06 Jul 2009

References

  • Balch C M, Soong S J, Shaw H M, . An analysis of prognostic factors in 4000 patients with cutaneous melanoma. Cutaneous melanoma: clinical management and treatment results worldwide, C M Balch, G W Milton, H M Shaw, et al. Lippincott, Philadelphia 1985; 321–52
  • Balch C M, Murad T M, Soong S J, et al. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 1978; 188: 732–42
  • Balch C M, Soong S J, Murad T M, et al. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979; 86: 343–53
  • Kaplan E L, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–81
  • Cox D. R. Regression models and life tables. J R Stat Soc 1972; B34: 187–220
  • Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin. Int J Cancer 1980; 26: 733–9
  • Cox E. B. Prognostic factors in malignant melanoma. Clinical management of melanoma, H F Seigler. Nijhoff, The Hague 1982; 279–330
  • Day C L, Sober A J, Kopf A W, et al. A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery 1981; 89: 599–603
  • Day C L, Sober A J, Kopf A W, et al. A prognostic model for clinical stage I melanoma of the trunk: location near the midline is not an independent risk factor for recurrent disease. Am J Surg 1981; 142: 247–51
  • Day C L, Sober A J, Kopf A W, et al. A prognostic model for clinical stage J. melanoma of the dipper extremity the importance of anatomic subsites in predicting recurrent disease. Ann Surg 1981; 193: 436–40
  • Eldh J, Boeryd B, Peterson L. E. Prognostic factors in cutaneous malignant melanoma in stage I: a clinical morphological and multivariate analysis. Scand J Plast Reconstr Surg 1978; 12: 243–55
  • Hacene K, Le Doussal V, Brunet M, et al. Prognostic index for clinical stage I cutaneous malignant melanoma. Cancer Res 1983; 43: 2991–6
  • Prade M, Bognel C, Charpentier P, et al. Malignant melanoma of the skin: prognostic factors derived from a multifactorial analysis of 239 cases. Am J Dermatopathol 1982; 4: 411–2
  • Schmoeckel C, Bockelbrink A, Bockelbrink H, et al. Low- and highrisk malignant melanoma. II. Multivariate analyses for a prognostic classification. Eur J Cancer Clin Oncol 1983; 19: 237–43
  • Schmoeckel C, Bockelbrink A, Bockelbrink H, et al. Low- and highrisk malignant melanoma. 1. Evaluation of clinical and histological prognostication in 585 cases. Eur J Cancer Clin Oncol 1983; 19: 227–36
  • Van der Esch E P, Cascinelli N, Preda F, et al. Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer 1981; 48: 1668–73
  • Day C L, Mihm M C, Lew R A, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51–3.99 mm): a conceptual model for tumour growth and metastases. Ann Surg 1982; 195: 35–43
  • Drzewiecki K T, Andersen P. K. Survival with malignant melanoma: a regression analysis of prognostic factors. Cancer 1982; 49: 2414–9
  • Cohen M H, Ketcham A S, Felix E L, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977; 186: 635–42
  • Day C L, Sober A J, Lew R A, et al. Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 1981; 47: 955–62
  • Callery C, Cochran A J, Roe D J, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982; 196: 69–75
  • Presant C A, Bartolucci A A, the Southeastern Cancer Study Group. Prognostic factors in metastatic malignant melanoma: the Southeastern Cancer Study Group experience. Cancer 1982; 49: 2192–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.